In March 2017, organisations from 17 European countries filed an opposition to Gilead Science's patent on the highly effective hepatitis C drug sofosbuvir. On 13th and 14th of September 2018, the hearing took e place before the European Patent Office in Munich. Photograph by Peter Bauza
Newsletter |
24 March 2021

World TB Day - FB Live: A journey with a TB survivor

COVID-19
Photograph by Peter Bauza
In March 2017, organisations from 17 European countries filed an opposition to Gilead Science's patent on the highly effective hepatitis C drug sofosbuvir. On 13th and 14th of September 2018, the hearing took e place before the European Patent Office in Munich. Photograph by Peter Bauza

On World Tuberculosis Day, we take a moment to stand with people living with TB. 

Continue Reading